SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-073836
Filing Date
2023-06-22
Accepted
2023-06-22 17:17:08
Documents
12
Period of Report
2023-06-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319442d1_8k.htm   iXBRL 8-K 36008
  Complete submission text file 0001104659-23-073836.txt   209738

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hepa-20230622.xsd EX-101.SCH 3221
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20230622_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20230622_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2319442d1_8k_htm.xml XML 3581
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 231034194
SIC: 2834 Pharmaceutical Preparations